Hospitalization costs for patients colonized with carbapenemase-producing Enterobacterales during an Australian outbreak.
J Hosp Infect
; 105(2): 146-153, 2020 Jun.
Article
em En
| MEDLINE
| ID: mdl-32179134
ABSTRACT
BACKGROUND:
Carbapenem-producing Enterobacterales are an expanding group of Gram-negative bacteria that are resistant to carbapenems and cause over 9000 cases of hospital-associated infections in the USA. Efforts to quantify the economic and societal burden to healthcare are important to inform resource planning to implement infection control programmes.AIM:
We estimated the healthcare costs during an outbreak of carbapenemase-producing Escherichia coli OXA-181 in Australia. We aimed to understand the economic burden to hospitals of patients who are asymptomatically colonized with high-risk bacteria.METHODS:
Hospital admissions data and associated costs were obtained from the State Health Department. Colonized patients were matched to non-colonized patients on age, sex, admission ward and diagnostic category. Mean healthcare costs and length of stay were examined using generalized linear models and accounted for time-dependent bias, patient age and ward location.FINDINGS:
On average, colonized patients had six times higher mean costs (AU$155,784; 95% confidence interval (CI) AU$77,892-285,604) than non-colonized patients (AU$25,964). Mean costs for those aged 75-79 years were 50% lower (P=0.02) compared with the youngest subgroup, 35-39 years of age. The mean extended length of stay was 12 days (95% CI 3-21) for colonized patients. Nursing care was the main driver of overall costs for colonized (44%) and non-colonized (39%) patients.CONCLUSION:
Patients colonized with carbapenem-producing Enterobacterales during an official hospital outbreak incurred higher costs than non-colonized patients. Although infected patients incur substantial economic burden to hospitals, the costs incurred by colonized patients is also high.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Preços Hospitalares
/
Escherichia coli
/
Infecções por Escherichia coli
/
Infecções Assintomáticas
/
Hospitalização
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article